Evidence map›Paper›PMID 40956852›Full record

ArticlePLOS digital health2025

Explainable cluster-based learning for prediction of postprandial glycemic events and insulin dose optimization in type 1 diabetes.

Najib Ur Rehman, Ivan Contreras, Aleix Beneyto, Josep Vehi

Abstract read
In one paragraph

Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Najib Ur RehmanDepartment of Electrical, Electronic and Automatic Engineering, Institut d'Informatica i Applicacions, Universitat de Girona, Girona, Spain.
Ivan ContrerasDepartment of Electrical, Electronic and Automatic Engineering, Institut d'Informatica i Applicacions, Universitat de Girona, Girona, Spain.ORCID https://orcid.org/0000-0001-6896-818X
Aleix BeneytoDepartment of Electrical, Electronic and Automatic Engineering, Institut d'Informatica i Applicacions, Universitat de Girona, Girona, Spain.ORCID https://orcid.org/0000-0001-8207-2259
Josep VehiDepartment of Electrical, Electronic and Automatic Engineering, Institut d'Informatica i Applicacions, Universitat de Girona, Girona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective management of postprandial glycemic excursions in type 1 diabetes requires accurate prediction of adverse events and personalized insulin adjustments informed by interpretable models. This study presents an explainable dual-prediction framework that simultaneously forecasts postprandial hypoglycemia and hyperglycemia within a 4-hour window using cluster-personalized ensemble models. Glycemic profiles were identified through a hybrid unsupervised approach combining self-organizing maps and k-means clustering, enabling the training of specialized random forest classifiers. The system outperformed baseline models on both real-world and simulated datasets, achieving high performance (AUC = 0.84 and 0.93; MCC = 0.47 and 0.73 for hypo- and hyperglycemia, respectively). Model interpretability was addressed using global (SHAP) and local (LIME) explanations, while interaction analysis revealed the non-linear effects of carbohydrate intake and insulin bolus combinations. An insulin adjustment module further refined pre-meal bolus recommendations based on predicted risk. Simulated evaluations confirmed improved postprandial time-in-range and reduced hypoglycemia without excessive hyperglycemia. These results underscore the potential of profile-driven and explainable machine learning approaches to support safer, individualized diabetes care.

Identifiers

PMID40956852
PMCPMC12440209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.